10 updates for 2026 clinical trial diversity mandates The regulatory environment of early 2026 is placing a strong emphasis on clinical trial diversity, with new mandates requiring pharmaceutical companies to enroll participants that reflect the actual racial, ethnic, and age demographics of the population. This shift is designed to ensure that new therapies are safe and effective for everyone, addressing the historical underrepresentation of...